
台股在台積電等電子股領漲下再創新高,外資雖續買超,但反手大砍擁有逾62萬股東的友達15.38萬張,加上自營商倒貨,導致友達股價慘摔5.32%,收在34.7元。
AI-generated summary
台股在電子股領漲下創下新高,外資持續買超台股但大幅拋售特定個股。
在外資與自營商聯手大砍友達,股價慘摔5.32%。(資料照)
AI續熱,台股在台積電、記憶體等電子股領漲下,指數終場上漲357點,收48157點,再創新高,雖然外資續買超373.13億元,但卻反手大砍擁有逾62萬股東的友達,在連2天買超逾48萬張後,今反手倒貨15.38萬張,不僅外資砍,自營商也倒貨8478張,受此衝擊,股價開平殺低,終場跌5.32%,收34.7元。
外資週三賣超前10大個股,依序為友達(2409)15萬3888張、群創(3481)4萬7830張、彩晶(6116)1萬9739張、臻鼎-KY(4958)1萬4428張、聯電(2303)1萬353張、仁寶(2324)9770張、臺企銀(2834)9087張、南亞(1303)8547張、新唐(4919)5755張、中信金(2891)5502張。

The Central Bank announced the financial situation in August. As the AI industry boom continues to heat up corporate capital needs, the annual growth rate of all monetary institutions' lending and investment rose to 9.43%, of which the annual growth rate of bank lending reached 10.49%, a new high since January 2005.

A publication under China’s industry ministry rejected 'de-CATLisation' market chatter as automakers diversify battery suppliers and CATL shares fall.

Industrial computer manufacturer IEI said at the press conference that its Netcom business will be its main growth engine this year, and its order visibility will extend to 2027. Israeli information security customers will contribute approximately 1.5 billion yuan. High-end video systems have been mass-produced since the second quarter, with momentum extending to 2028, and the company is actively exploring physical AI robot business opportunities.

Tesla CEO Elon Musk praised Chinese President Xi Jinping as a great and capable leader in an interview with state broadcaster CCTV, citing the nation's immense prosperity under his tenure.
Zhou Ningren, a global senior managing partner at McKinsey, pointed out that the future competition in China’s banking industry will shift from scale competition to value creation competition. As business models differentiate and artificial intelligence accelerates its popularity, banks need to effectively combine technology with wealth management and promote AI from scattered pilots to large-scale value release.
Bank of China launched the "Drug Traceability Code" factoring business and the "1+4" service matrix, and supported the innovative development and internationalization process of biopharmaceutical companies throughout the chain through innovative products such as "Pipeline R&D Loan" and "BD Loan".